Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia [6]

British Journal of Haematology

Volumn 130, Issue 5, 2005, Pages 801-803

  Goemans, B F ^a   Zwaan, Ch M ^a,b   Martinelli, S ^c   Harrell, P ^d   De Lange, D ^a   Carta, C ^c   Reinhardt, D ^e   Hahlen K ^c,f   Creutzig, U ^e   Tartaglia, M ^b   Heinrich, M C ^d   Kaspers, G J L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e AML BFM Study Group   (Germany)

^f DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

Author keywords

FAB M5 AML; Geographical differences; Paediatric AML; PTPN11 mutation

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 11; UNCLASSIFIED DRUG; SIGNAL PEPTIDE; SRC HOMOLOGY 2 (SH2) DOMAIN CONTAINING PHOSPHATASES; SRC HOMOLOGY-2 (SH2) DOMAIN-CONTAINING PHOSPHATASES;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COHORT ANALYSIS; EXON; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPOTHESIS; LETTER; MALE; METHODOLOGY; PREVALENCE; PRIORITY JOURNAL; ACUTE DISEASE; ACUTE MONOCYTIC LEUKEMIA; GENETIC PREDISPOSITION; GENETICS; INFANT; MUTATION; MYELOID LEUKEMIA; PRESCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MUTATION; PREVALENCE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 27244441024     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05685.x     Document Type: Letter

References (3)

1. Douer D. ( 2003) The epidemiology of acute promyelocytic leukaemia. Best Practice & Research. Clinical Haematology, 16, 357 367.
2. Goemans B.F. Zwaan C.M. Miller M. Zimmermann M. Harlow A. Meshinchi S. Loonen A.H. Hahlen K. Reinhardt D. Creutzig U. Kaspers G.J. Heinrich M.C. ( 2005) Mutations in KIT and RAS are frequent events in pediatric core binding factor acute myeloid leukemia. Leukemia, in press Meshinchi S. ( 2004) PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group. Leukemia, 18, 1831 1834.
3. Tartaglia M. Kalidas K. Shaw A. Song X. Musat D.L. van der Burgt I. Brunner H.G. Bertola D.R. Crosby A. Ion A. Kucherlapati R.S. Jeffery S. Patton M.A. Gelb B.D. ( 2002) PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. American Journal of Human Genetics, 70, 1555 1563 Biondi A. ( 2005) Somatic PTPN11 mutations in childhood acute myeloid leukaemia. British Journal of Haematology, 129, 333 339.